![Akshay Vaishnaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 3 M $ au 31/05/2026
Le Dr Akshay K. Vaishnaw est directeur indépendant de Scholar Rock Holding Corp. et d'Editas Medicine, Inc. et président de la recherche et du développement d'Alnylam Pharmaceuticals, Inc. et membre du Royal College of Physicians. Il siège au conseil d'administration de Scholar Rock Holding Corp, Scholar Rock, Inc. et Editas Medicine, Inc. Le Dr Vaishnaw était auparavant employé par Biogen Idec, Inc. en tant que directeur principal de la médecine translationnelle. Il a également siégé au conseil d'administration de Visterra, Inc. Il a obtenu son diplôme de premier cycle à l'université de Cardiff, un doctorat à la faculté de médecine de l'université de Cardiff et un doctorat à l'université de Londres.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2026 | 58 521 ( 0,05% ) | 3 M $ | 31/05/2026 | |
| 01/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Technique/Scientifique/R&D | 27/04/2025 |
| HEMAB THERAPEUTICS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/01/2024 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 07/07/2009 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 01/05/2019 |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Directeur/Membre du Conseil | 01/01/2024 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/03/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | President | 02/10/2023 |
| EDITAS MEDICINE, INC. | Directeur/Membre du Conseil | 30/06/2024 |
| VISTERRA INC | Directeur/Membre du Conseil | 01/07/2018 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
 University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Cardiff University School of Medicine
 Cardiff University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Hemab ApS
Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Health Technology |
HEMAB THERAPEUTICS INC.
 HEMAB THERAPEUTICS INC. BiotechnologyHealth Technology Engages in research and development of prophylactic therapeutics for bleeding disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
